Table 1 Baseline demographics and laboratory characteristics of the primary cohort.
COVID-19 | Other viral PNA | Bacterial PNA | Clinical PNA | Other infections | Other diseases | |
|---|---|---|---|---|---|---|
Demographics | ||||||
Total, n | 447 | 405 | 1515 | 1862 | 256 | 663 |
Female, n (%) | 202 (45) | 192 (47) | 570 (38) | 865 (46) | 138 (54) | 276 (42) |
Age, years | ||||||
Mean ± SD | 42 ± 17 | 53 ± 22 | 74 ± 17 | 73 ± 19 | 45 ± 21 | 61 ± 21 |
Median (IQR) | 39 (28–57) | 52 (35–70) | 77 (65–87) | 79 (62–88) | 39 (29–59) | 64 (46–79) |
16–35 | 174 (39) | 101 (25) | 46 (3) | 117 (6) | 104 (41) | 105 (16) |
35–50 | 113 (25) | 87 (21) | 85 (6) | 147 (8) | 62 (24) | 82 (12) |
50–65 | 115 (26) | 83 (20) | 237 (16) | 281 (15) | 37 (14) | 152 (23) |
> 65 | 45 (10) | 134 (33) | 1147 (76) | 1317 (71) | 53 (21) | 324 (49) |
Haemoglobin g/dL | ||||||
Missing, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Mean ± SD | 13.9 ± 1.4 | 12.9 ± 2.2 | 11.1 ± 2.4 | 11.4 ± 2.5 | 13.2 ± 2.0 | 12.0 ± 2.6 |
Median (IQR) | 13.9 (13.0–15.0) | 13.2 (11.7–14.6) | 11.1 (9.3–12.8) | 11.7 (9.7–13.2) | 13.4 (12.1–14.5) | 12.4 (10.3–14.0) |
Haematocrit | ||||||
Missing, n (%) | 0 (0) | 0 (0) | 0 (0) | 1 (0) | 0 (0) | 0 (0) |
Mean ± SD | 0.4 ± 0.0 | 0.4 ± 0.1 | 0.3 ± 0.1 | 0.3 ± 0.1 | 0.4 ± 0.1 | 0.4 ± 0.1 |
Median (IQR) | 0.4 (0.4–0.4) | 0.4 (0.4–0.4) | 0.3 (0.3–0.4) | 0.4 (0.3–0.4) | 0.4 (0.4–0.4) | 0.4 (0.3–0.4) |
WBC, 109/L | ||||||
Missing, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Mean ± SD | 5.5 ± 1.9 | 8.8 ± 4.8 | 12.6 ± 12.9 | 11.3 ± 6.7 | 9.4 ± 5.5 | 11.5 ± 21.5 |
Median (IQR) | 5.2 (4.3–6.4) | 7.7 (6.0–10.2) | 11.1 (7.5–15.4) | 9.8 (7.1–13.7) | 7.7 (6.3–10.5) | 9.0 (6.8–12.4) |
Lymphocyte, 109/L | ||||||
Missing, n (%) | 4 (1) | 48 (12) | 97 (6) | 108 (6) | 17 (7) | 43 (6) |
Mean ± SD | 1.3 ± 0.6 | 1.4 ± 0.8 | 1.1 ± 2.1 | 1.2 ± 1.5 | 1.7 ± 1.1 | 1.4 ± 2.5 |
Median (IQR) | 1.3 (0.9–1.7) | 1.3 (0.8–1.8) | 0.9 (0.5–1.4) | 1.0 (0.6–1.5) | 1.6 (1.0–2.1) | 1.2 (0.7–1.7) |
Monocyte 109/L | ||||||
Missing, n (%) | 4 (1) | 48 (12) | 100 (7) | 108 (6) | 17 (7) | 44 (7) |
Mean ± SD | 0.5 ± 0.2 | 0.6 ± 0.4 | 0.7 ± 1.0 | 0.8 ± 1.8 | 0.6 ± 0.4 | 0.7 ± 0.9 |
Median (IQR) | 0.5 (0.3–0.6) | 0.6 (0.4–0.8) | 0.6 (0.4–0.9) | 0.6 (0.4–0.9) | 0.5 (0.3–0.7) | 0.6 (0.4–0.9) |
Neutrophil 109/L | ||||||
Missing, n (%) | 4 (1) | 48 (12) | 97 (6) | 108 (6) | 17 (7) | 43 (6) |
Mean ± SD | 3.6 ± 1.7 | 6.7 ± 4.8 | 10.4 ± 7.4 | 9.1 ± 5.5 | 7.1 ± 5.6 | 8.4 ± 5.7 |
Median (IQR) | 3.3 (2.4–4.4) | 5.4 (3.9–7.8) | 8.9 (5.8–13.5) | 7.8 (5.1–11.6) | 5.2 (3.9–8.3) | 6.7 (4.5–10.6) |
Platelet 109/L | ||||||
Missing, n (%) | 0 (0) | 0 (0) | 4 (0) | 2 (0) | 0 (0) | 0 (0) |
Mean ± SD | 221.2 ± 74.1 | 233.3 ± 87.4 | 246.0 ± 117.7 | 241.2 ± 108.7 | 234.1 ± 81.2 | 255.4 ± 108.4 |
Median (IQR) | 205.0 (171.0–259.0) | 223.0 (173.0–280.0) | 231.0 (169.5–307.0) | 224.5 (168.0–294.0) | 233.0 (179.0–281.2) | 236.0 (188.0–301.0) |
CRP mg/dL | ||||||
Missing, n (%) | 48 (11) | 181 (45) | 610 (40) | 638 (34) | 122 (48) | 292 (44) |
Mean ± SD | 1.9 ± 4.0 | 4.9 ± 7.7 | 9.9 ± 9.6 | 7.4 ± 8.1 | 5.7 ± 9.4 | 5.9 ± 8.0 |
Median (IQR) | 0.4 (0.2–1.4) | 1.9 (0.4–6.0) | 7.1 (2.1–15.2) | 4.9 (1.1–11.0) | 0.7 (0.1–7.0) | 2.1 (0.3–8.8) |
LDH U/L | ||||||
Missing, n (%) | 31 (7) | 250 (62) | 936 (62) | 1020 (55) | 146 (57) | 347 (52) |
Mean ± SD | 208.9 ± 74.8 | 238.1 ± 124.7 | 371.9 ± 625.5 | 287.0 ± 344.9 | 198.5 ± 73.4 | 296.8 ± 500.6 |
Median (IQR) | 186.5 (158.0–237.0) | 210.0 (165.0–253.2) | 252.6 (193.7–353.0) | 226.5 (184.0–290.0) | 177.0 (155.5–212.0) | 210.5 (178.0–293.2) |
